– ISRAEL, Petah Tikva – Macrocure Ltd. (NASDAQ:MCUR), today announced that as the Company continues to explore potential strategic alternatives, Tomer Kariv, a current Director on the Company’s Board and CEO & Founder of Pontifax, will become Chairman of the Board replacing David Ben-Ami, current Chairman of the Company’s Board of Directors, who will remain a member of Macrocure’s Board of Directors. Mark Page, Chief Financial Officer, will be stepping down from his position at Macrocure by February 2016 to pursue other opportunities. Shai Lankry, current VP Finance and former CFO of Macrocure, will be assuming Mark’s responsibilities. Dr. Michael Molyneaux, Chief Medical Officer, will also step down from his position in December.
Nissim Machiach, President & Chief Executive Officer said, “On behalf of the Board, we would like to profoundly thank David, Mark and Mike for their leadership and contributions to Macrocure. Finally, we are grateful to Tomer for assuming the Chairman role and to David for his continuing Board participation while the Company continues to explore potential strategic alternatives. The Company is in process of selecting and appointing an outside advisory firm to assist with this review.”
About Macrocure Ltd.
Macrocure Ltd. is a clinical-stage biotechnology company that until recently was focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
